Edesa Biotech, Inc. (EDSA)
4.35
+2.07
(+90.79%)
USD |
NASDAQ |
Mar 03, 16:00
4.85
+0.50
(+11.49%)
After-Hours: 05:23
Edesa Biotech Total Liabilities (Quarterly) : 0.7562M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 10.74M |
| Aurinia Pharmaceuticals, Inc. | 189.26M |
| Lexaria Bioscience Corp. | 1.527M |
| Xenon Pharmaceuticals, Inc. | 399.91M |
| ProMIS Neurosciences, Inc. | 12.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.71M |
| Shareholders Equity (Quarterly) | 13.95M |
| Current Ratio | 16.82 |
| Net Debt Paydown Yield | 0.03% |